SPA Pricing Education, Analytics & Decision Making Tools Webinar Series

Tag: Drug Pricing

Nevada forces drugmakers to reveal insulin pricing, profits | Las Vegas Sun Newspaper

Nevada forces drugmakers to reveal insulin pricing, profits | Las Vegas Sun Newspaper

After a long road to passage, Senate Bill 539, which creates transparency in prescription drugs used to treat diabetes, was signed into law by Gov. Brian Sandoval on Thursday. Sandoval vetoed the original bill, in what he called a difficult decision, because of a clause that would have mandated drug makers to provide public notice […]

Trump Administration Prepares a Drug Pricing Executive Order, Sources Say | Bloomberg

Trump Administration Prepares a Drug Pricing Executive Order, Sources Say | Bloomberg

Top health and budget officials in the administration will meet Friday to discuss the issue, according to the people, who asked not to be identified because the session is private. Trump sought recommendations from the nation’s health agencies on reducing medication costs, Health and Human Services Secretary Tom Price told senators last week. One policy […]

Nevada passes insulin drug pricing transparency bill | Business Insider

Nevada passes insulin drug pricing transparency bill | Business Insider

Nevada is one of 23 states with proposed legislation to take on the rising cost of prescription drugs. But unlike others that focus on drug prices in a general sense, the hybrid bill focuses on two specific groups of drugs that are used to treat diabetes: insulin and biguanides. It’s the latest milestone in government actions at the […]

Can Drug Price Reductions Help or Hinder Pfizer Inc. ? | Library for Smart Investors (LFSI)

Can Drug Price Reductions Help or Hinder Pfizer Inc. ? | Library for Smart Investors (LFSI)

Pfizer Inc. (NYSE:PFE) so far has not joined the price reduction party and of course this has investors of the Interfaith Center on Corporate Responsibility (ICCR) worried. The news of Pfizer Inc.’s (NYSE:PFE) recent price hack made headlines earlier this month. The company jacked up the prices of 91 drugs by about a staggering 20%. […]

Pfizer investors slam new price increases as ‘out of step’ with its Big Pharma rivals | FiercePharma

Pfizer investors slam new price increases as ‘out of step’ with its Big Pharma rivals | FiercePharma

A host of Big Pharmas have either promised to limit their price hikes or opened up info on their increases and rebates. But Pfizer isn’t one of them—and that has some investors riled. In the wake of a new round of price hikes reported by the Financial Times, investor members of the Interfaith Center on […]

Value-based contracts key to solving U.S. drug pricing ‘crisis’ | Modern Healthcare

Value-based contracts key to solving U.S. drug pricing ‘crisis’ | Modern Healthcare

In one of the deals between the two, Harvard Pilgrim pays Eli Lilly a lower price for its Type 2 diabetes drug Trulicity if patients do better on competing diabetes drugs. We’re “putting our money where are mouth is—not just making claims about superiority, but measuring outcomes,” Ricks explained. The two CEOs see the value-based […]

Drug-Pricing Regulator Wants Medical Devices Added To Price Control List | NDTV Profit

Drug-Pricing Regulator Wants Medical Devices Added To Price Control List | NDTV Profit

India’s drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for price controls to reduce costs to patients, which if agreed could be another blow to the country’s $5 billion-a-year medical-technology industry. The National Pharmaceutical Pricing Authority (NPPA) had said it did not plan further […]

EpiPen Not Overpriced, Despite New York Times Complaint | Reason.com

EpiPen Not Overpriced, Despite New York Times Complaint | Reason.com

Yet consider that for $609, or, for about 90% of people, less than $100 out of pocket, the company is offering a year’s worth of access to potentially life-saving medicine, in a reliable delivery system. Compare that to the pricing of The New York Times: $1,014 for a yearlong seven-day-a-week home delivery subscription to a […]

Mylan chairman: Drug pricing critics ought to go copulate with themselves | Ars Technica

Mylan chairman: Drug pricing critics ought to go copulate with themselves | Ars Technica

Some pharmaceutical companies are troubled by stratospheric drug prices. Several have vowed to limit price hikes, for instance. And the powerful drug lobbying group PhRMA is at least trying to distract consumers’ attention away from price gouging by dangling shiny advertisements about their life-saving research. But there are some companies that just don’t care. Mylan […]

CSRxP launches campaign in Colorado to hold big pharma accountable for out-of-control drug prices | Rocky Mountain Post

CSRxP launches campaign in Colorado to hold big pharma accountable for out-of-control drug prices | Rocky Mountain Post

The Campaign for Sustainable Rx Pricing (CSRxP), a broad-based coalition of leaders from every sector in healthcare, launched a campaign in Colorado and nationally as part of a multi-million-dollar effort to hold Big Pharma accountable for the rising prices of prescription drugs. Because Big Pharma blocks competition to maintain monopolies on medicines, they can set any price they […]